European RWE & Market Access Summit
Conference Focus
New European HTA era, real-world evidence, market access
Overview
The European RWE & Market Access Summit 2026 is a premier industry gathering focused on the intersection of real-world evidence (RWE) and market access strategies. As the European pharmaceutical landscape shifts toward a new Health Technology Assessment (HTA) era, this summit provides a critical platform for stakeholders to discuss the integration of RWE into regulatory and reimbursement decision-making. The event brings together industry leaders, payers, and policy experts to navigate the complexities of evidence generation, value demonstration, and patient access in a rapidly evolving regulatory environment. Organized by WLCUS, the summit is distinguished by its focus on practical applications of RWE to support commercial success and clinical operations. Attendees gain insights into aligning clinical development with payer requirements, optimizing evidence portfolios, and ensuring long-term product viability. It serves as a vital forum for bridging the gap between clinical data and commercial strategy, making it essential for those navigating the new European HTA framework.
Why Attend
Professionals should attend to gain actionable strategies for navigating the new European HTA landscape. The summit offers unparalleled networking with industry peers, payers, and regulators, facilitating high-level discussions on evidence generation and market access. Attendees will leave with a deeper understanding of how to leverage RWE to accelerate patient access, optimize commercial value, and ensure regulatory compliance in a competitive European market.
Key Topics & Sessions
- •New European HTA Regulation Implementation
- •RWE Strategy for Regulatory Submission
- •Evidence Generation for Payer Negotiations
- •Bridging Clinical Trials and Real-World Data
- •Digital Health and RWE Integration
- •Patient-Reported Outcomes (PROs) in Market Access
- •Cross-Border HTA Collaboration
- •Optimizing Value Dossiers
- •Post-Market Surveillance and Evidence
- •Rare Disease Market Access Challenges
Who Should Attend
Conference History
WLCUS has established a strong reputation for hosting specialized pharmaceutical summits. This event series has grown to become a key fixture in the European calendar, reflecting the increasing importance of RWE in the evolving regulatory landscape and the industry's need for collaborative forums.
Venue & Location
Amsterdam, Netherlands. Specific venue details are typically provided upon registration confirmation.
Related Conference Categories
This conference covers topics in the following pharma and life sciences domains. Explore more events in each category using our conference directory filters.
Resources & Links
About European RWE & Market Access Summit
European RWE & Market Access Summit is a in-person event scheduled for 2026-10-21 to 2026-10-22 in Amsterdam, Netherlands. The conference focuses on new european hta era, real-world evidence, market access. This event is categorized under Commercial & Marketing, Clinical Operations in our conference directory.
The European RWE & Market Access Summit 2026 is a premier industry gathering focused on the intersection of real-world evidence (RWE) and market access strategies. As the European pharmaceutical landscape shifts toward a new Health Technology Assessment (HTA) era, this summit provides a critical platform for stakeholders to discuss the integration of RWE into regulatory and reimbursement decision-making. The event brings together industry leaders, payers, and policy experts to navigate the complexities of evidence generation, value demonstration, and patient access in a rapidly evolving regulatory environment. Organized by WLCUS, the summit is distinguished by its focus on practical applications of RWE to support commercial success and clinical operations. Attendees gain insights into aligning clinical development with payer requirements, optimizing evidence portfolios, and ensuring long-term product viability. It serves as a vital forum for bridging the gap between clinical data and commercial strategy, making it essential for those navigating the new European HTA framework.
Professionals attending conferences like European RWE & Market Access Summit gain access to cutting-edge insights, peer networking, and exposure to the latest technologies shaping the pharmaceutical and biotechnology sectors. Whether you are evaluating new vendors, seeking regulatory updates, or expanding your professional network, industry conferences remain one of the most effective ways to stay current in life sciences.
Looking for guidance on which conferences to attend or how to build your event strategy for 2026? Book a meeting with the IntuitionLabs team to discuss your priorities and how we can support your team.